Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Intuitive Surgical, Inc. (ISRG) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $383.42, indicating a +0.28% shift from the previous trading day.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reachead $400.24 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $391.71, moving -0.6% from the previous trading session.
Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Hyperfine (HYPR) delivered earnings and revenue surprises of 11.76% and 26.61%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $390.53 in the latest trading session, marking a -0.53% move from the prior day.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical, Inc. (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical's (ISRG) Da Vinci 5 Receives FDA Approval
by Zacks Equity Research
Intuitive Surgical (ISRG) announces the FDA clearance for its next-generation robotic system, da Vinci 5, which is likely to improve surgical workflow and save significant time with better care.
Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $382.99, marking a -1.65% move from the previous day.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Intuitive Surgical, Inc. (ISRG) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $400.59, representing a +0.68% change from its previous close.
Why Is Thermo Fisher (TMO) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Universal Health (UHS) Q4 Earnings Beat on Adjusted Admissions
by Zacks Equity Research
Universal Health (UHS) expects net revenues between $15.411 billion and $15.706 billion for 2024, which indicates 8.9% year-over-year growth.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $386.37, indicating a -0.49% shift from the previous trading day.
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.
Wall Street Bulls Look Optimistic About Intuitive Surgical, Inc. (ISRG): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical, Inc. (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Is Intuitive Surgical, Inc. (ISRG) Up 2.8% Since Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $380.23, denoting a +0.69% change from the preceding trading day.
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.